Effect of Chromium Picolinate Supplementation on Diabetic Profile and Nutritional Status of the Type-2 Diabetic Adult Population – A Randomized Controlled Trial

Hajra Ahmad¹, Zaheer Ahmed^1, and Rezzan Khan²

¹Department of Home & Health Sciences, Allama Iqbal Open University Islamabad, Pakistan

²Consultant Nutritionist, Shifa International Hospital, Sector H-8/4, Islamabad, Pakistan

Cite this paper:
Hajra Ahmad, Zaheer Ahmed and Rezzan Khan. Effect of Chromium Picolinate Supplementation on Diabetic Profile and Nutritional Status of the Type-2 Diabetic Adult Population – A Randomized Controlled Trial. Journal of Food and Nutrition Research. 2016; 4(8):535-542. doi: 10.12691/jfnr-4-8-8

Abstract

The health impacts of Chromium Picolinate (CrP) have been searched by various researchers particularly focused on management of Type-2 Diabetes Mellitus (T2DM) with the conflicting results. The objective of the present study was to investigate the role of CrP on management of T2DM. It was a randomized controlled trial (RCT). Two groups of newly diagnosed Type -2 diabetics between the age brackets of 40-65 years were randomly selected from diabetes clinic. One group was exposed to 200 μg of CrP per day and the other was given a capsule of inert material as placebo having no impact on diabetic profile. The intervention duration was 03 months followed by one month as washout period. The outcome variables were biochemistry related to diabetic profile, clinical signs symptoms and toxicity if any. Dietary profile and anthropometrics were used for nutritional assessment. The study revealed that 82.7% of the subjects had family history of diabetes among which 59.6% were close relative. 98.1% were suffering from some kind of stress. Diabetic profile such as FPG, HbA1c and insulin levels improved in terms of normality after three months in treatment group, but did not come to the normal acceptable range e.g. The FPG dropped from142.85±17.71 to 130.42±32.68 mg/dl with a significant P value of 0.003 within the phases. Other health indicators such as lipid profile, blood pressure and clinical signs symptoms also improved and more in treatment group. Dietary counseling showed positive effects on food intake. Renal and hepatic profile showed no signs of toxicity in treatment group. The study concluded that CrP combined with dietary counseling had positive effect on diabetic profile of the newly diagnosed T2DM patients. The clinical signs and symptoms were improved. No hepatic and renal toxicity was observed.

Keywords:
chromium HbA1c Fasting blood glucose lipid liver profile

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Doddigarla Z., Parwez I., Ahmad J, “Correlation of serum chromium, zinc, magnesium and SOD levels with HbA1c in type 2 diabetes: A cross sectional analysis”, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2015.
[2]	Yin, R.V., Phung, O.J, “Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus”, Nutrition journal, 14:1. 2015.
[3]	Joseph, E., DiSilvestro, R., de Blanco, E.J.C, “Triglyceride lowering by chromium picolinate in type 2 diabetic people” International Journal of Nutrition and Metabolism, 7.24-28. 2015.
[4]	Rocha, N.R., Carrara, M.A., Stefanello, T.F., Teixeira, C.J., Oliveira, A.C.P., Batista, M.R, “Effects of chromium picolinate supplementation in type 2 diabetic patients”, Acta Scientiarum Health Sciences, 36.161-164.2014.
[5]	Ghosh, D., Bhattacharya, B., Mukherjee, B., Manna, B., Sinha, M., Chowdhury, J, et al. “Role of chromium supplementation in Indians with type 2 diabetes mellitus” The Journal of nutritional biochemistry, 13.690-697. 2002.
[6]	Xie, W., Zhao, Y., Zhang, Y, “Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus” Evidence-Based Complementary and Alternative Medicine, 2011, 2011.
[7]	Nolan, C.J., Damm, P., Prentki, M, “Type 2 diabetes across generations: from pathophysiology to prevention and management”, The Lancet, 378,169-81.2011.
[8]	Raghavan, S., Porneala, B., McKeown, N., Fox, C.S., Dupuis, J., Meigs, J.B, Metabolic factors and genetic risk mediate familial type 2 diabetes risk in the Framingham Heart Study, Diabetologia, 58. 988-96. 2015.
[9]	Alwan, A, “Global status report on noncommunicable diseases 2010” World Health Organization, 2011.
[10]	Shaw, J.E., Sicree, R.A., Zimmet, P.Z, “Global estimates of the prevalence of diabetes for 2010 and 2030”, Diabetes research and clinical practice. 87. 4-14. 2010.
[11]	Guariguata, L., Whiting, D., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J, “Global estimates of diabetes prevalence for 2013 and projections for 2035”, Diabetes research and clinical practice, 103.137-49. 2014.
[12]	Parkin, C.G., Davidson, J.A, “Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes”, Journal of diabetes science and technology. 3:500-508.2009.
[13]	Somineni, H.K., Boivin, G.P., Elased, K.M, Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice, Journal of Endocrinology, 221.235-251. 2014.
[14]	Balk, E.M., Tatsioni, A., Lichtenstein, A.H., Lau, J., Pittas, A.G, “Effect of chromium supplementation on glucose metabolism and lipids a systematic review of randomized controlled trials”, Diabetes care, 30. 2154-2163. 2007.
[15]	Sharma, S., Agrawal, R.P., Choudhary, M., Jain, S., Goyal, S., Agarwal, V, “Beneficial effect of chromium supplementation on glucose, HbA 1 C and lipid variables in individuals with newly onset type-2 diabetes”, Journal of Trace Elements in Medicine and Biology, 25. 149-153. 2011.
[16]	Anderson, R.A, “Chromium and insulin resistance”, Nutrition research reviews, 16. 267-275. 2003.
[17]	Cefalu, W.T., Rood, J., Pinsonat, P., Qin, J., Sereda, O., Levitan, L., Anderson, R.A., Zhang, X.H., Martin, J.M., Martin, C.K. and Wang, Z.Q, Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism. 59. 755-762. 2010.
[18]	Abdollahi, M., Farshchi, A., Nikfar, S. and Seyedifar, M, “Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials”, Journal of Pharmacy & Pharmaceutical Sciences, 16. 99-114. 2013.
[19]	American Diabetes Association, Classification and Diagnosis of Diabetes. Diabetes Care, 39. S13-S22. 2016.
[20]	Marfell-Jones, M.J., Stewart, A., de Ridder, J, International standards for anthropometric assessment, 2012.
[21]	Streiner, D.L., Norman, G.R., Cairney, J, Health measurement scales: a practical guide to their development and use: Oxford University Press, USA; 2014.
[22]	Crozier, S.R., Inskip, H.M., Godfrey, K.M., Robinson, S.M, “Dietary patterns in pregnant women: a comparison of food-frequency questionnaires and 4 d prospective diaries”, British journal of nutrition, 99. 869-875. 2008.
[23]	Tyrovolas, S., Pounis, G., Bountziouka, V., Polychronopoulos, E., Panagiotakos, D.B, “Repeatability and validation of a short, semi-quantitative food frequency questionnaire designed for older adults living in Mediterranean areas: the MEDIS-FFQ”, Journal of Nutrition for the Elderly, 2010;29:311-24.
[24]	Manual A. Dietary guidelines for Indians. Nat Inst Nutrition. 2. 89-117. 2011.
[25]	Lau, F.C., Bagchi, M., Sen, C.K., Bagchi, D, “Nutrigenomic basis of beneficial effects of chromium (III) on obesity and diabetes”, Molecular and cellular biochemistry, 317. 1-10. 2008.
[26]	Paiva, A.N., de Lima, J.G., de Medeiros, A.C., Figueiredo, H.A., de Andrade, R.L., Ururahy, M.A., Rezende, A.A., Brandão-Neto, J. and Almeida, M.D.G, “Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study”, Journal of Trace Elements in Medicine and Biology, 32. 66-72. 2015.
[27]	Kelly, S.J., Ismail, M, “Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes”, Annual review of public health, 36. 441-462. 2015.
[28]	Mendenhall, E., Norris, S.A., Shidhaye, R., Prabhakaran, D, “Depression and type 2 diabetes in low-and middle-income countries: a systematic review”, Diabetes research and clinical practice, 103. 276-285. 2014.
[29]	Tabák, A.G., Akbaraly, T.N., Batty, G.D., Kivimäki, M, “Depression and type 2 diabetes: a causal association?” The lancet Diabetes & endocrinology, 2. 236-245. 2014.
[30]	Cheng, N., Zhu, X., Shi, H., Wu ,W., Chi, J., Cheng, J., and Anderson, R.A, “Follow‐up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium” The Journal of Trace Elements in Experimental Medicine, 12. 55-60. 1999.
[31]	Alhazmi, A., Stojanovski, E., McEvoy, M., Garg, M, “The association between dietary patterns and type 2 diabetes: a systematic review and meta‐analysis of cohort studies” Journal of Human Nutrition and Dietetics, 27. 251-60. 2014.
[32]	Costanzo, P., Cleland, J.G., Pellicori, P., Clark, A.L., Hepburn, D., Kilpatrick, E.S., Perrone-Filardi, P., Zhang, J. and Atkin, S.L, “The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study”, Annals of internal medicine, 162. 610-618. 2015.
[33]	Zhang, Q., Xiao, X., Li, M., Li, W., Yu, M., Zhang, H., Ping, F., Wang, Z., Zheng, J. and Xiang, H, “miR-375 and miR-30d in the effect of chromium-containing Chinese medicine moderating glucose metabolism”, Journal of diabetes research, 2014. 2014.
[34]	Hummel, M., Standl, E., Schnell, O, “Chromium in metabolic and cardiovascular disease”, Hormone and metabolic research, 39. 743-751. 2007.
[35]	Wang, Z.Q., Qin, J., Martin, J., Zhang, X.H., Sereda, O, Anderson RA, Pinsonat, P. and Cefalu, W.T, “Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation”, Metabolism, 56. 1652-1655. 2007.
[36]	Bartlett, H.E., Eperjesi, F, “Nutritional supplementation for type 2 diabetes: a systematic review”, Ophthalmic and physiological optics, 28. 503-523. 2008.
[37]	Aghdassi, E., Arendt, B.M., Salit, I.E., Mohammed, S.S., Jalali, P., Bondar, H., Allard, J.P, “In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial”, Current HIV research, 8. 113-120. 2010.
[38]	Jain, S.K., Rains, J.L., Croad, J.L, “Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats”, Free Radical Biology and Medicine, 43. 1124-1131. 2007.
[39]	Sundaram, B., Aggarwal, A., Sandhir, R, “Chromium picolinate attenuates hyperglycemia-induced oxidative stress in streptozotocin-induced diabetic rats”, Journal of Trace Elements in Medicine and Biology, 27. 117-121. 2013.